Cargando…

Association of Ki-67 Change Pattern After Core Needle Biopsy and Prognosis in HR+/HER2− Early Breast Cancer Patients

BACKGROUND: To investigate the association of Ki-67 change pattern after core needle biopsy (CNB) and prognosis in HR+/HER2− early breast cancer patients. METHOD: Eligible patients were categorized into three groups: Low group, Elevation group, and High group. Chi-square test and logistic regression...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Shuai, Chen, Xiaosong, Shen, Kunwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Surgery
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275673/ https://www.ncbi.nlm.nih.gov/pubmed/35836600 http://dx.doi.org/10.3389/fsurg.2022.905575

Ejemplares similares

Ki67 increase after core needle biopsy associated with worse disease outcome in HER2-negative breast cancer patients
por: Tong, Yiwei, et al.
Publicado: (2023)

Clinical validation of Ki67 by quantitative reverse transcription-polymerase chain reaction (RT-PCR) in HR+/HER2- early breast cancer
por: Gao, Weiqi, et al.
Publicado: (2019)

Surgery time interval and molecular subtype may influence Ki67 change after core needle biopsy in breast cancer patients
por: Chen, Xiaosong, et al.
Publicado: (2015)

HER2-Low Status Is Not Accurate in Breast Cancer Core Needle Biopsy Samples: An Analysis of 5610 Consecutive Patients
por: Lu, Yujie, et al.
Publicado: (2022)

CEA-Ki-67- Pathologic Subtype: An Adjunct Factor for Refining Prognosis in Stage I Pulmonary Adenocarcinoma
por: Yu, Dongzhi, et al.
Publicado: (2022)

Progesterone Receptor Status and Ki-67 Index May Predict Early Relapse in Luminal B/HER2 Negative Breast Cancer Patients: A Retrospective Study
por: Zong, Yu, et al.
Publicado: (2014)

A real-world retrospective study of the use of Ki-67 testing and treatment patterns in patients with HR+, HER2− early breast cancer in the United States
por: Brown, Jacqueline, et al.
Publicado: (2022)

Ki-67 and breast cancer prognosis: does it matter if Ki-67 level is examined using preoperative biopsy or postoperative specimen?
por: Choi, Soon Bo, et al.
Publicado: (2022)

21-Gene Recurrence Assay Associated With Favorable Metabolic Profiles in HR-Positive, HER2-Negative Early-Stage Breast Cancer Patients
por: Zhu, Yifei, et al.
Publicado: (2021)

Ki67 and the apparent diffusion coefficient in postoperative prostate cancer with endocrine therapy
por: He, Jun, et al.
Publicado: (2023)

The relationship between Ki-67 expression and imaging signs and pathological features in GISTs
por: Xiao, Lin, et al.
Publicado: (2023)

Prognostic and predictive value of Ki-67 in triple-negative breast cancer
por: Wang, Wei, et al.
Publicado: (2016)

Apoptosis and Ki-67 as predictive factors for response to radiation therapy in feline nasal lymphomas
por: FU, Dah-Renn, et al.
Publicado: (2016)

A Preliminary Analysis of Ki-67 Expression in Breast Cancer in the Caribbean
por: Jogie, Joshua A, et al.
Publicado: (2023)

Changes of Tumor Infiltrating Lymphocytes after Core Needle Biopsy and the Prognostic Implications in Early Stage Breast Cancer: A Retrospective Study
por: Huang, Jiahui, et al.
Publicado: (2019)

An HR-MAS MR Metabolomics Study on Breast Tissues Obtained with Core Needle Biopsy
por: Li, MuLan, et al.
Publicado: (2011)

Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
por: Cheang, Maggie C. U., et al.
Publicado: (2009)

Conversion of ER, PR, HER2 and Ki-67 and Prognosis in breast cancer metastases to the brain
por: Jiaxin, Chen, et al.
Publicado: (2022)

Preoperative core needle biopsy is accurate in determining molecular subtypes in invasive breast cancer
por: Chen, Xiaosong, et al.
Publicado: (2013)

Factors influencing agreement of breast cancer luminal molecular subtype by Ki67 labeling index between core needle biopsy and surgical resection specimens
por: Tendl-Schulz, Kristina A., et al.
Publicado: (2020)

Breast Metastasis of Lung Cancer After Computed Tomography-Guided Core Needle Biopsy: A Case Report
por: Zhao, Rong, et al.
Publicado: (2022)

Prognostic Utility of Apoptosis Index, Ki-67 and Survivin Expression in Dogs with Nasal Carcinoma Treated with Orthovoltage Radiation Therapy
por: FU, Dah-Renn, et al.
Publicado: (2014)

Pre-operative Prediction of Ki-67 Expression in Various Histological Subtypes of Lung Adenocarcinoma Based on CT Radiomic Features
por: Huang, Zhiwei, et al.
Publicado: (2021)

Evaluation of hormone receptor, human epidermal growth factor receptor-2 and Ki-67 with core needle biopsy and neoadjuvant chemotherapy effects in breast cancer patients
por: Ge, Wen-kai, et al.
Publicado: (2015)

Is Endoscopic Ultrasound-Fine Needle Aspiration for Ki67 Aspirational Enough?
por: David, Yakira, et al.
Publicado: (2020)

Clinical characteristics, tumor‐infiltrating lymphocytes, and prognosis in HER2‐low breast cancer: A comparison study with HER2‐zero and HER2‐positive disease
por: Lu, Yujie, et al.
Publicado: (2023)

Ki-67, an elusive marker in the prognosis of breast cancer
por: Sood, Neelam
Publicado: (2019)

The relationship between the expression of Ki-67 and the prognosis of osteosarcoma
por: Zeng, Ming, et al.
Publicado: (2021)

Can HER2 1+ Breast Cancer Be Considered as HER2-Low Tumor? A Comparison of Clinicopathological Features, Quantitative HER2 mRNA Levels, and Prognosis among HER2-Negative Breast Cancer
por: Shu, Lan, et al.
Publicado: (2022)

Clinicopathological Features and Disease Outcome in Breast Cancer Patients with Hormonal Receptor Discordance between Core Needle Biopsy and Following Surgical Sample
por: Zhu, Siji, et al.
Publicado: (2019)

Associations of clinicopathological factors with local treatment and survival outcome in elderly patients with ductal carcinoma in situ
por: Zhang, Xu, et al.
Publicado: (2023)

Diagnostic Accuracy of ki-67 Labeling Index in Endoscopic Ultrasonography-Fine-Needle Aspiration Cytology and Biopsy of Pancreatic Neuroendocrine Neoplasms
por: Pyo, Jung-Soo, et al.
Publicado: (2023)

A nomogram to predict the high-risk RS in HR+/HER2-breast cancer patients older than 50 years of age
por: Yu, Jing, et al.
Publicado: (2021)

Evaluation of Ki67 Expression across Distinct Categories of Breast Cancer Specimens: A Population-Based Study of Matched Surgical Specimens, Core Needle Biopsies and Tissue Microarrays
por: Knutsvik, Gøril, et al.
Publicado: (2014)

De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study
por: Guarneri, V, et al.
Publicado: (2019)

Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies
por: Romero, Quinci, et al.
Publicado: (2011)

HR-MAS MR Spectroscopy of Breast Cancer Tissue Obtained with Core Needle Biopsy: Correlation with Prognostic Factors
por: Choi, Ji Soo, et al.
Publicado: (2012)

Needle core biopsy for breast lesions: An audit of 467 needle core biopsies
por: Radhakrishna, Selvi, et al.
Publicado: (2013)

HER2 positivity is not associated with adverse prognosis in high-risk estrogen receptor-positive early breast cancer patients treated with chemotherapy and trastuzumab
por: Li, Shuai, et al.
Publicado: (2020)

Analysis of the influencing factors on fine-needle aspiration biopsy results of the thyroid
por: Wang, Chun-Yan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b2v4md74tgsirdnci2rpk2ehbi